Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy

NCT: NCT07553975 · NOT_YET_RECRUITING

NCT IDNCT07553975
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2029-05-01

Brief Summary

The study is a pilot study designed to generate preliminary data regarding the cost of ACL surgery using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting.

Frequently Asked Questions

What is Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy?

Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy is a clinical trial registered under NCT07553975. Current status: NOT_YET_RECRUITING.

What is the status of NCT07553975?

The current status of NCT07553975 (Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy) is: NOT_YET_RECRUITING.

When did Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy start?

Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑